AI Visibility Scorecard
RECOMBINATE™ [Antihemophilic Factor (Recombinant)] Discontinuation
recombinate.com · Healthcare
Borderline visible. AI bots can crawl RECOMBINATE™ [Antihemophilic Factor (Recombinant)] Discontinuation, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 9 times
Claude · Meta AI
#46,659 of 924,420 in Healthcare for AI visibility
<1
4
AEO Visibility
iBorderline · 4.2/10
25
Muse Index Score
iAI agent readiness
Basic · 25/100
0
AI Adoption
iNone detected · 0/100
About RECOMBINATE™ [Antihemophilic Factor (Recombinant)] Discontinuation
from our crawl and measurement
RECOMBINATE, based in Cambridge, MA, describes itself simply: "RECOMBINATE is being discontinued, but support is available. Explore next steps, alternative Takeda FVIII treatment options, and transition assistance." When AI engines look at it, they find little to work with. It scores 4.2 out of 10.
Our crawl found structured data on the page (MedicalWebPage), a sitemap and a readable heading structure. It is missing an llms.txt file.
AI crawlers have visited once in our tracking, including ClaudeBot (Anthropic).
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Strong
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Good
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 4.2/10, RECOMBINATE™ [Antihemophilic Factor (Recombinant)] Discontinuation is crawlable but under-signaled - fixable, and the signals above are where to start.
Frequently Asked Questions
What are the possible side effects of RECOMBINATE [Antihemophilic Factor (Recombinant)]?
You could have an allergic reaction to RECOMBINATE. Call your healthcare provider right away and stop treatment if you get a: rash or hives itching tightness of the throat chest pain or tightness difficulty breathing light-headed, dizziness fainting The most common side effects are chills, flushing, rash, and nose bleeds. These are not all the possible side effects with RECOMBINATE.
What else should I know about RECOMBINATE [Antihemophilic Factor (Recombinant)] and hemophilia A?
Your body may form inhibitors to Factor VIII. An inhibitor is part of the body’s normal defense system. If you form inhibitors, it may stop RECOMBINATE from working properly. Call your healthcare provider right away if your bleeding does not stop after taking RECOMBINATE. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for the development of inhibitors to Factor VIII.
Is this your brand?
The exact fixes for RECOMBINATE™ [Antihemophilic Factor (Recombinant)] Discontinuation
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for RECOMBINATE™ [Antihemophilic Factor (Recombinant)] Discontinuation.
Source & Attribution
Scored by Engagemii on August 10, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/recombinate
Cite this score: Engagemii (2026). "AEO Score for RECOMBINATE™ [Antihemophilic Factor (Recombinant)] Discontinuation." Retrieved from https://engagemii.com/aeo/brands/recombinate
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform